INS and metabolic syndrome: In a pilot study, lean donor FMT into nine obese males with metabolic syndrome induced a small but significant improvement in peripheral insulin sensitivity and a trend toward improved hepatic insulin sensitivity when compared to participants that underwent autologous gut microbiota infusion.